Top compounds associated with response to ARHGEF7


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 3e-10
mRNA PX-12 CTRPv2 pan-cancer AAC 0.18 1e-09
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.23 5e-09
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.2 6e-09
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 1e-08
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 1e-08
mRNA Carboplatin CTRPv2 pan-cancer AAC 0.21 2e-08
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.19 2e-08
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC 0.2 2e-08
mRNA Topotecan CTRPv2 pan-cancer AAC 0.18 2e-08
Download CSV